Press Releases | Medtronic

Month Year

Email alerts

Feb 13, 2013

AIRvance(TM) Bone Screw System Gains Additional FDA Clearance

The AIRvance(TM) Bone Screw System Is Now Suitable for the Performance of a Hyoid Suspension Procedure, Which Can Be Used in Combination with Other Procedures for the Treatment of Obstructive Sleep Apnea

MINNEAPOLIS - Feb. 13, 2013 - Medtronic announced today that it has received Food and Drug Administration (FDA) clearance for its AIRvance(TM) Bone Screw System that allows surgeons to perform a...
Feb 11, 2013

Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2013

MINNEAPOLIS - Feb. 11, 2013 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2013 on Tuesday, February 19, 2013. A news...
Feb 5, 2013

Ricky Rubio, La Estrella De Los Minnesota Timberwolves Colabora Con La Fundación Medtronic Para Salvar La Vida De Jóvenes Víctimas De Paro Cardíaco Súbito

Rubio ayuda a los visitantes de la página web a salvar una vida "virtual" en HeartRescueNow.com

MINNEAPOLIS, 5 de febrero, 2013 - Ricky Rubio, la estrella de los Minnesota Timberwolves se une a la fundación Medtronic durante este mes de febrero para salvar la vida de jóvenes de todo el...
Feb 4, 2013

Medtronic Announces CE Mark of Evera® Portfolio of Implantable Cardioverter-Defibrillators

Next-Generation ICDs Offer Patients Proven Treatment Performance, Increased Longevity, Improved Comfort

MINNEAPOLIS - February 4, 2013 - Medtronic today announced CE (Conformité Européenne) Mark of the Evera® portfolio of implantable cardioverter-defibrillators (ICD). With increased longevity and...
Feb 3, 2013

Minnesota Timberwolves Star Ricky Rubio Teams Up with Medtronic Foundation to Save Young Lives from Sudden Cardiac Arrest

Rubio Helps Web Visitors Save a "Virtual" Life at HeartRescueNow.com

MINNEAPOLIS, February 5, 2013 -Minnesota Timberwolves basketball star Ricky Rubio joins the Medtronic Foundation this February in saving young lives worldwide from sudden cardiac arrest (SCA)....
Jan 30, 2013

Medtronic Introduces the First and Only Neurostimulation Systems with CE Mark Approval for Full-Body MRI Scans

TOLOCHENAZ AND MINNEAPOLIS - January 30, 2013 - Medtronic, Inc. (NYSE: MDT) today introduced in Europe the first and only implantable neurostimulation systems indicated for use in the treatment of...
Jan 30, 2013

Medtronic Completes Strategic Investment in LifeTech Scientific Corporation

Strategic Alliance to Leverage Best of Both Companies to Reach Cardiovascular Patients in China and Other Emerging Markets

MINNEAPOLIS and Shenzhen - January 30, 2013 - Medtronic, Inc. (NYSE:MDT) and LifeTech Scientific Corporation (8122:HK) today announced the closing of a transaction creating a strategic alliance...
Jan 28, 2013

Medtronic Initiates Landmark Study of Neurostimulation Therapy for Failed Back Surgery Syndrome

First Patients Treated in Global Clinical Trial Evaluating Impact of Therapy on Predominant Low Back Pain

MINNEAPOLIS - January 28, 2013 - Medtronic, Inc. (NYSE: MDT) today announced the start of PROMISE, a Prospective, Randomized Study of Multicolumn Implantable Lead Stimulation for Predominant Low...
Jan 24, 2013

Medtronic Launches Lower-Extremity Indication for Complete 'SE' Vascular Stent Internationally

Self-Expanding Peripheral Device Gets CE Mark for Superficial Femoral and Proximal Popliteal Arteries

MINNEAPOLIS -- Jan. 24, 2013 -- Expanding its role in the treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced the CE (Conformité Européene) mark and international...
Jan 23, 2013

Medtronic Drug-Eluting Balloon Study Completes Enrollment

Milestone in IN.PACT SFA II Brings FDA Submission for Promising Interventional Treatment of Peripheral Artery Disease One Step Closer in U.S.

MINNEAPOLIS -- Jan. 23, 2013 -- Medtronic, Inc. (NYSE: MDT), today announced completion of enrollment in IN.PACT SFA II, the U.S. arm of its clinical study for the IN.PACT Admiral drug-eluting...

Show per page